Zone 2 for disease states

When clinicians prescribe exercise — and in hypertension, prediabetes, and cardiac rehabilitation they genuinely do — the prescription is almost always the same intensity band this site calls zone 2. This page covers why base work became the clinical default: the trials, the mechanisms, and the cautions that apply when you are training with a diagnosis rather than merely for one.

Why Clinics Reach for Moderate Intensity First

Medicine's preference for the moderate band is partly physiology and partly pragmatics. Physiologically, the zone-2 range is where large muscle groups work steadily for extended periods without accumulating lactate — which, in a patient whose cardiovascular system is already compromised, is the intensity with the widest margin between stimulus and harm. Pragmatically, moderate continuous exercise is what participants in clinical trials actually complete: adherence survives it, which is more than can be said for the harder protocols. The result is that the deepest body of exercise-as-medicine evidence — diabetes prevention, blood pressure, cardiac rehabilitation — was built almost entirely on work that sits in or near zone 2, which is why the Metabolic pillar's insulin-resistance topic keeps pointing back here.

Hypertension: A Meaningful Share of a Drug's Effect

In the largest meta-analysis of its kind, endurance training lowered resting blood pressure by about 3.5 mmHg systolic and 2.5 mmHg diastolic across all participants — and by roughly 8.3 / 5.2 mmHg among people with hypertension (Cornelissen & Smart, JAHA, 2013). Context is everything here: a 5 mmHg systolic reduction at the population level translates into meaningful reductions in stroke and heart attack, and single antihypertensive drugs typically buy somewhere in the same neighborhood. Exercise is a genuine contributor to blood-pressure control — but it is an adjunct, not a substitute. If you are on medication, the lifestyle work is added on top, and the dosing conversation belongs to your clinician, not this page. The blood-pressure topic owns the measurement and medication detail; the protocol page turns it into a plan.

Prediabetes: The Trial That Made Exercise a Prescription

The landmark diabetes-prevention trials are the strongest exercise-as-medicine evidence in existence. The US Diabetes Prevention Program randomized high-risk adults to placebo, metformin, or an intensive lifestyle program — the lifestyle arm aimed at 150 minutes per week of moderate activity plus about 7% weight loss — and cut the development of type 2 diabetes by 58% over roughly three years, beating metformin's 31% (Knowler et al., NEJM, 2002). The Finnish Diabetes Prevention Study, with a nearly identical prescription, found the same 58% reduction (Tuomilehto et al., NEJM, 2001). Follow-up analyses showed the effect persisted for years after the trials ended.

The mechanism is not mysterious. Contracting muscle pulls glucose from the blood through a pathway that does not depend on insulin, and doing that for 30–60 minutes most days is a direct, repeated attack on the insulin-resistance spiral. Zone 2 adds a second layer: it rebuilds the mitochondrial fat-oxidation capacity that is measurably impaired in metabolic syndrome (San Millán & Brooks, Sports Medicine, 2018). A short walk after the largest meal of the day has an outsized effect on the post-meal glucose excursion — the cheapest glucose-management tool there is.

Cardiac Rehabilitation: The Original Zone 2 Program

Cardiac rehab is the oldest and most studied exercise prescription in medicine — and it has been, since the beginning, mostly moderate continuous work. The Cochrane evidence, updated by Anderson and colleagues (JACC, 2016), shows that exercise-based rehabilitation after coronary events reduces cardiovascular mortality by about 26% and hospital admissions by roughly 18%. An earlier randomized comparison made the point even more sharply: in patients with stable coronary disease, a year of regular exercise improved event-free survival at least as well as a stent procedure, at a fraction of the risk (Hambrecht et al., NEJM, 2000). In heart failure, the large HF-ACTION trial found exercise training produced modest but real reductions in hospitalization and a trend toward lower mortality (O'Connor et al., JAMA, 2009).

One honest refinement: interval training works in these populations too. In heart failure, supervised aerobic intervals improved fitness more than continuous moderate training in a landmark comparison (Wisløff et al., Circulation, 2007). The reason zone 2 remains the clinical default is not that it is uniquely effective — it is that it needs the least supervision, carries the least acute risk, and accumulates the most total volume, which is the variable most reliably tied to outcomes.

Clinician Territory, Stated Plainly

⚠️ If you have any of the conditions on this page, exercise planning is a clinical decision, not a self-service one. The specifics:

• 🫀 After a cardiac event or with known heart disease: exercise should start in a supervised rehabilitation setting, typically following exercise testing. This is the standard of care in most countries for a reason.
• 🛑 Stop-and-tell symptoms: chest pain or pressure, dizziness or near-fainting, unusual breathlessness, or a racing irregular heartbeat during exercise are stop conditions, not push-through conditions. Tell your clinician.
• 🍬 Diabetes-specific cautions: check glucose before and after sessions while learning your response; carry fast-acting carbohydrate; and avoid starting exercise with very high glucose plus ketones or with hypoglycemia. Medication doses — especially insulin and sulfonylureas — may need adjusting, which is a prescriber's job.
• 💊 Medication timing: antihypertensives, diuretics, and diabetes drugs interact with exercise timing and hydration. Bring your full medication list to whoever supervises your training.

Nothing in this pillar replaces that conversation. The value of these pages for you is context — knowing what the evidence says so you can have the conversation well.

Questions, Answered Briefly

• 🚶 Is walking enough in these conditions? Frequently yes — supervised walking programs are the backbone of cardiac rehab, and brisk walking was the dominant activity in the diabetes-prevention trials. Intensity matters less than consistency at this stage.
• 💊 Can exercise replace medication? Generally no. Exercise reduces risk and improves control, but in hypertension and after cardiac events the medications remain first-line treatment. Adjusting or stopping them is a clinician's decision.
• ⚡ What about intervals in disease populations? Supervised interval training shows promise — better fitness gains in heart failure (Wisløff et al., Circulation, 2007) — but it demands closer supervision and more screening. This is precisely a clinician-territory question.

Related Topics